Osteonic Co. Ltd Capital Reinvestment Ratio

Latest as of September 2025: 1.39x

Osteonic Co. Ltd capital reinvestment ratio. Osteonic Co. Ltd (226400) has a Capital Reinvestment Ratio of 1.39x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩1.09 Billion) in capital expenditures (₩1.52 Billion). See Osteonic Co. Ltd (226400) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

1.39x
Capex / Operating Cash Flow

Operating Cash Flow

₩1.09 Billion
KRW

Capital Expenditures

₩1.52 Billion
KRW

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Osteonic Co. Ltd (2018–2024)

Capital reinvestment ratio of Osteonic Co. Ltd from 2018 to 2024. This chart tracks Osteonic Co. Ltd's Capital Reinvestment Ratio across 6 annual periods. See 226400 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Osteonic Co. Ltd Capital Reinvestment Ratio by Year (2018–2024)

Osteonic Co. Ltd capital reinvestment ratio by year from 2018 to 2024. For the full cash flow conversion analysis, see Osteonic Co. Ltd (226400) cash flow conversion.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2024 1.49x ₩4.72 Billion ₩7.05 Billion ▼ -11.3%
2023 1.68x ₩4.14 Billion ₩6.97 Billion ▲ +1294.5%
2022 0.12x ₩3.99 Billion ₩481.34 Million ▼ -62.1%
2021 0.32x ₩2.95 Billion ₩939.46 Million ▼ -7.5%
2020 0.34x ₩2.75 Billion ₩949.15 Million ▼ -97.9%
2018 16.58x ₩317.53 Million ₩5.26 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow